PRFX Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Valuation Metrics

The current forward P/E ratio for PainReform Ltd (PRFX.O) is -0.02, compared to its 5-year average forward P/E of -3.10. For a more detailed relative valuation and DCF analysis to assess PainReform Ltd 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-3.10

Current PE

-0.02

Overvalued PE

0.71

Undervalued PE

-6.90

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

Annual

Quarterly

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

PRFX News & Events

Events Timeline

No data

News

3.5

12-02Newsfilter

PainReform Initiates OcuRing-K Development Plan Targeting 4.5 Million Cataract Surgeries Annually

3.5

12-02Globenewswire

PainReform Initiates OcuRing-K Development Plan Targeting Ophthalmic Market

3.5

11-12Newsfilter

PainReform's DeepSolar Progresses in Developing AI-Powered Automated Reporting System for Solar Asset Evaluation

People Also Watch

Frequently Asked Questions

What is PainReform Ltd (PRFX) stock price today?

The current price of PRFX is 0.8875 USD — it has decreased -8.55 % in the last trading day.

What is PainReform Ltd (PRFX)'s business?

PAINREFORM LTD is a Israel-based pharmaceutical Company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.

What is the price predicton of PRFX Stock?

Wall Street analysts forecast PRFX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for PRFX is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is PainReform Ltd (PRFX)'s revenue for the last quarter?

PainReform Ltd revenue for the last quarter amounts to -7.35M USD, increased 226.15 % YoY.

What is PainReform Ltd (PRFX)'s earnings per share (EPS) for the last quarter?

PainReform Ltd. EPS for the last quarter amounts to -4954000.00 USD, increased 147.33 % YoY.

What changes have occurred in the market's expectations for PainReform Ltd (PRFX)'s fundamentals?

The market is revising No Change the revenue expectations for PainReform Ltd. (PRFX) for FY2025, with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -33.77%.

How many employees does PainReform Ltd (PRFX). have?

PainReform Ltd (PRFX) has 2 emplpoyees as of December 15 2025.

What is PainReform Ltd (PRFX) market cap?

Today PRFX has the market capitalization of 3.80M USD.